Lionhunter Capital Management, LLC’s AstraZeneca AZN Stock Holding History

Lionhunter Capital Management, LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	+6,000	New	+$1.13M	0.51%	51

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $148B AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Lionhunter Capital Management, LLC's AZN Position: Q2 2026 in Review

Lionhunter Capital Management, LLC opened a new position in AstraZeneca (AZN) in Q2 2026: 6,000 shares worth $1.14M. The stake represents 0.51% of the portfolio and ranks #51 among its holdings.

1,253 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Lionhunter Capital Management, LLC held 6,000 shares of AstraZeneca worth $1.14M as of Q2 2026.
AstraZeneca was a new Lionhunter Capital Management, LLC position in Q2 2026.
AstraZeneca made up 0.51% of Lionhunter Capital Management, LLC's portfolio in Q2 2026, its #51 holding.
1,253 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Lionhunter Capital Management, LLC's 13F filing for Q2 2026, filed 13 Aug 2026.